BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16458488)

  • 1. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).
    Liu J; Ball SL; Yang Y; Mei P; Zhang L; Shi H; Kaminski HJ; Lemmon VP; Hu H
    Mech Dev; 2006 Mar; 123(3):228-40. PubMed ID: 16458488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular characterization of abnormal brain development in protein o-mannose N-acetylglucosaminyltransferase 1 knockout mice.
    Liu J; Yang Y; Li X; Zhang P; Qi Y; Hu H
    Methods Enzymol; 2010; 479():353-66. PubMed ID: 20816176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
    Miyagoe-Suzuki Y; Masubuchi N; Miyamoto K; Wada MR; Yuasa S; Saito F; Matsumura K; Kanesaki H; Kudo A; Manya H; Endo T; Takeda S
    Mech Dev; 2009; 126(3-4):107-16. PubMed ID: 19114101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice.
    Takahashi H; Kanesaki H; Igarashi T; Kameya S; Yamaki K; Mizota A; Kudo A; Miyagoe-Suzuki Y; Takeda S; Takahashi H
    Mol Cell Neurosci; 2011 Jun; 47(2):119-30. PubMed ID: 21447391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene.
    Teber S; Sezer T; Kafali M; Manzini MC; Konuk Yüksel B; Tekin M; Fitöz S; Walsh CA; Deda G
    Eur J Paediatr Neurol; 2008 Mar; 12(2):133-6. PubMed ID: 17881266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.
    Hehr U; Uyanik G; Gross C; Walter MC; Bohring A; Cohen M; Oehl-Jaschkowitz B; Bird LM; Shamdeen GM; Bogdahn U; Schuierer G; Topaloglu H; Aigner L; Lochmüller H; Winkler J
    Neurogenetics; 2007 Nov; 8(4):279-88. PubMed ID: 17906881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
    Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
    J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.
    Uribe ML; Haro C; Ventero MP; Campello L; Cruces J; Martín-Nieto J
    Mol Vis; 2016; 22():658-73. PubMed ID: 27375352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
    Endo T
    Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of length and amino acid sequence of O-mannosyl peptides on substrate specificity of protein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1 (POMGnT1).
    Akasaka-Manya K; Manya H; Mizuno M; Inazu T; Endo T
    Biochem Biophys Res Commun; 2011 Jul; 410(3):632-6. PubMed ID: 21684258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features.
    Haliloglu G; Gross C; Senbil N; Talim B; Hehr U; Uyanik G; Winkler J; Topaloglu H
    Acta Myol; 2004 Dec; 23(3):137-9. PubMed ID: 15938569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents.
    Zhang W; Vajsar J; Cao P; Breningstall G; Diesen C; Dobyns W; Herrmann R; Lehesjoki AE; Steinbrecher A; Talim B; Toda T; Topaloglu H; Voit T; Schachter H
    Clin Biochem; 2003 Jul; 36(5):339-44. PubMed ID: 12849864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M
    Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
    Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
    Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease.
    Manya H; Sakai K; Kobayashi K; Taniguchi K; Kawakita M; Toda T; Endo T
    Biochem Biophys Res Commun; 2003 Jun; 306(1):93-7. PubMed ID: 12788071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant.
    Clement EM; Godfrey C; Tan J; Brockington M; Torelli S; Feng L; Brown SC; Jimenez-Mallebrera C; Sewry CA; Longman C; Mein R; Abbs S; Vajsar J; Schachter H; Muntoni F
    Arch Neurol; 2008 Jan; 65(1):137-41. PubMed ID: 18195152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
    Voglmeir J; Kaloo S; Laurent N; Meloni MM; Bohlmann L; Wilson IB; Flitsch SL
    Biochem J; 2011 Jun; 436(2):447-55. PubMed ID: 21361872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.